The Drug-Drug Interactions Ontology

Last uploaded: February 11, 2016

Preferred Name	cetuximab
Synonyms
ID	http://purl.obolibrary.org/obo/dinto_DB00002
ATCCode	L01XC06
binds	http://purl.obolibrary.org/obo/dinto_3109 http://purl.obolibrary.org/obo/dinto_3105 http://purl.obolibrary.org/obo/dinto_3106 http://purl.obolibrary.org/obo/dinto_3107 http://purl.obolibrary.org/obo/dinto_3078 http://purl.obolibrary.org/obo/dinto_3084 http://purl.obolibrary.org/obo/dinto_3112 http://purl.obolibrary.org/obo/dinto_3111 http://purl.obolibrary.org/obo/dinto_3709 http://purl.obolibrary.org/obo/dinto_3461 http://purl.obolibrary.org/obo/dinto_3466 http://purl.obolibrary.org/obo/dinto_2792
blocks	http://purl.obolibrary.org/obo/dinto_2792
CASRN	205923-56-4
DBBrand	erbitux
DBSynonym	imc-c225 anti egfr
Definition	Epidermal growth factor receptor binding FAB. Cetuximab is composed of the Fv (variable; antigen-binding) regions of the 225 murine EGFr monoclonal antibody specific for the N-terminal portion of human EGFr with human IgG1 heavy and kappa light chain constant (framework) regions.
has pharmacological target	http://purl.obolibrary.org/obo/dinto_2792
label	cetuximab
modulates	http://purl.obolibrary.org/obo/dinto_2792
prefixIRI	obo2:dinto_DB00002
prefLabel	cetuximab
related with	http://purl.obolibrary.org/obo/dinto_3109 http://purl.obolibrary.org/obo/dinto_3105 http://purl.obolibrary.org/obo/dinto_3106 http://purl.obolibrary.org/obo/dinto_3107 http://purl.obolibrary.org/obo/dinto_3078 http://purl.obolibrary.org/obo/dinto_3084 http://purl.obolibrary.org/obo/dinto_3112 http://purl.obolibrary.org/obo/dinto_3111 http://purl.obolibrary.org/obo/dinto_3709 http://purl.obolibrary.org/obo/dinto_3461 http://purl.obolibrary.org/obo/dinto_3466
xref	National Drug Code Directory:66733-948-23 Drugs.com:http://www.drugs.com/cdi/cetuximab.html GenBank:J00228 RxList:http://www.rxlist.com/cgi/generic3/erbitux.htm Wikipedia:http://en.wikipedia.org/wiki/Cetuximab PharmGKB:PA10040
subClassOf	http://purl.obolibrary.org/obo/dinto_000055

Add comment

Add proposal

Subscribe to notes emails

Delete	Subject	Author	Type	Created
No notes to display

Create mapping

Mapping To	Ontology	Source
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1723	NCIT	LOOM
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1723	ROO	LOOM
http://purl.bioontology.org/ontology/NDDF/008568	NDDF	LOOM
http://purl.bioontology.org/ontology/MESH/D000068818	MESH	LOOM
http://purl.bioontology.org/ontology/npo#NPO_577	NPO	LOOM
http://purl.obolibrary.org/obo/NCIT_C1723	BERO	LOOM
http://purl.bioontology.org/ontology/LNC/LP220476-8	LOINC	LOOM
http://purl.obolibrary.org/obo/OMIT_0001333	OMIT	LOOM
http://ontology.lst.tfo.upm.es/BD2D/chemo#Cancer_Therapy_Agent_Name@@2	HENECON	LOOM
http://purl.obolibrary.org/obo/DRON_00018764	PDRO	LOOM
http://purl.obolibrary.org/obo/DRON_00018764	DDSS	LOOM
http://purl.obolibrary.org/obo/DRON_00018764	DRON	LOOM
http://www.drugbank.ca/drugs/DB00002	FTC	LOOM
http://purl.bioontology.org/ontology/SNOMEDCT/409400001	SNOMEDCT	LOOM
http://purl.bioontology.org/ontology/ATC/L01FE01	ATC	LOOM
http://purl.jp/bio/4/id/200906015776372378	IOBC	LOOM
http://sbmi.uth.tmc.edu/ontology/ochv#C0995188	OCHV	LOOM
https://go.drugbank.com/drugs/DB00002	MDM	LOOM
http://www.phoc.org.cn/pmo/class/PMO_00022038	PMAPP-PMO	LOOM
http://purl.bioontology.org/ontology/PDQ/CDR0000042384	PDQ	LOOM
http://purl.bioontology.org/ontology/PDQ/CDR0000042384	PDQ	LOOM
http://purl.bioontology.org/ontology/RXNORM/318341	RXNORM	LOOM
http://purl.bioontology.org/ontology/VANDF/4021419	VANDF	LOOM
http://purl.bioontology.org/ontology/NDFRT/N0000148833	NDFRT	LOOM
http://purl.obolibrary.org/obo/MESH_D000068818	BERO	LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#C411189	RH-MESH	LOOM
http://ontology.lst.tfo.upm.es/SPT/follow#Cancer_Therapy_Agent_Name_rec_met@@2	HENEGEO	LOOM
http://sbmi.uth.tmc.edu/ontology/ochv#53884	OCHV	LOOM